     |
||||||||||||||||||||
|
|
||||||||||||||||||||
|
|
Rheumatoid arthritis testLab tests, a physical exam, x-rays, and possibly a test for the rheumatoid factor. The rheumatoid factor is a test that detects an antibody that is found in roughly 80pct. of people with RA. Please be aware that there is currently no single test that will tell you if you do in fact have Rheumatoid Arthritis.
X-rays cannot confirm the presence of rheumatoid arthritis, but they are used to rule out other diseases. X-rays also establish a baseline for comparison as the disease progresses. The Latex test is used to diagnose rheumatoid arthritis. This test detects an antibody in the blood called the rheumatoid factor. Rheumatoid factor is present in the blood when the body reacts to inflammation in the synovial membranes. It is not always present at the beginning of the disease, but as the condition progresses, most patients with rheumatoid arthritis test positive for it. The rheumatoid factor is not exclusively a product of rheumatoid arthritis. It is an antibody produced in response to inflammation and other diseases that cause inflammation can also result in an elevated rheumatoid factor. These situations are rare, however, and the Latex test can confirm a preliminary diagnosis of rheumatoid arthritis.
 2010-03-10 Arthritis and Lupus Drugs Pulled Off by Pharma Companies TopNews United StatesFollowing many deaths, rheumatoid arthritis and lupus drugs are being pulled off by Swiss pharmaceutical companies Roche and Biogen. After being observed by monitoring board, the two drugs were found to be immensely infectious and even deadly in some cases. Roche had said that before the drug was proved to be causing some serious infections, earlier last year, at the last stage of its trail, was confirmed that it had a powerful impact on curbing the effect of rheumatoid arthritis.
2010-03-09 UPDATE 4-Roche, Biogen suspends arthritis drug after deaths ReutersRoche said last year a late-stage trial of ocrelizumab showed it significantly reduced the signs and symptoms of rheumatoid arthritis, a painful joint disease, but that it was associated with a higher number of serious infections. (ID:nGEE5BA04M) The drug was expected to succeed Rituxan when its patent expired, said Helvea analyst Karl-Heinz Koch. Rituxan records sales of around 900 million Swiss francs ( usd. 841. 9 million) in rheumatoid arthritis, Koch said. Ocrelizumab, developed by Roches Genentech unit and Biogen, is similar to Rituxan, which is already approved to treat cancer and rheumatoid arthritis. * Also suspends ocrelizumab RA development programme * Safety monitoring board detects serious infections * Roche stock closes near flat; Biogen up 1. 9 percent (Adds comment from Roche, updates - (Western Europe Europe Switzerland Health and medicine Pharmaceuticals (sub-industry) Pharmaceuticals - diversified Central and Eastern Europe Healthcare Pharmaceuticals and biotechnology
2010-03-07 Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study - 7thSpace InteractiveExploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study Rheumatoid arthritis (RA) is a chronic, inflammatory and systemic disease which affects the musculoskeletal system. Exercise programmes are reported to improve physical functioning in patients with RA. Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study - up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment, Headlines, Recipes and more. A place for the whole family featuring many different sections to chose from.
2010-03-06 Healthy Living: Rheumatoid arthritis - News 10 NowResearchers have been able to work backwards and come up with drugs that block that inflammation and these drugs called biologic response modifiers are drugs that specifically block specific proteins, cytokines is the more technical names are elevated in patients who have rheumatologist arthritis," said Greenstein. Rheumatoid arthritis affects the joints, leaving them somewhat disfigured and painful. The most common symptom is joint stiffness, especially in the morning. Millions of Americans suffer from joint pain but today, a diagnosis of arthritis is much different than it was in the past. Healthy Living: Rheumatoid arthritis - Marcie fraser health rheumatoid arthritis health good good for you healthy living fitstop syracuse news weather news News10 news10syracuse north country rome mohawk valley new york
2010-03-05 Arthritis drug too costly for England (but not Scotland) Mail OnlineThousands of rheumatoid arthritis sufferers in England could be condemned to a lifetime of pain after the drugs rationing body turned down a last chance treatment available in Scotland. The decision came a day after NICE turned down another drug for rheumatoid arthritis, Orencia, which could have benefited 3,500. Both decisions will force sufferers to use ineffective steroids. Thousands of rheumatoid arthritis sufferers in England could be condemned to a lifetime of pain after the drugs rationing body turned down a last chance treatment available in Scotland. - Arthritis drug costly England Scotland
2010-03-04 Drug Cleared for Treating Moderate to Severe Rheumatoid Arthritis - Renal and Urology NewsRoche has received marketing clearance for Actemra (tocilizumab) as a treatment for moderate to severe active rheumatoid arthritis (RA) in adults who have had an inadequate response to one or more treatments that block tumor necrosis factor. Tocilizumab, which is a monoclonal antibody, works by blocking interleukin-6, a key cytokine involved in inflammation and is overabundant in RA patients. The drug may be used alone or in combination with methotrexate or other disease-modifying anti-rheumatic drugs. The drug is approved for once-monthly IV administration. Roche has received marketing clearance for Actemra (tocilizumab) as a treatment for moderate to severe active rheumatoid arthritis (RA) in adults who have had an inadequate response to one or more treatments that block tumor necrosis factor. - Urology drugs nephrology drugs FDA FDA News drug approval device approval prescribing information FDA Alerts Drugs medicine medication CME drug information device information Food and Drug
2010-03-02 GTC Provides Update on TG20 Monoclonal Antibody Targeting CD20 - MarketWatchThis result is an important demonstration of the ability of GTCs transgenic technology platform to produce monoclonal antibodies with significantly enhanced ADCC", said Geoffrey Cox, Ph. D. , Chairman, President and CEO of GTC Biotherapeutics. "Furthermore, this is a critical milestone in our development of TG20, an antibody that has the potential of providing more efficacious and cost-effective treatments for cancers such as non-Hodgkins lymphoma as well as auto-immune diseases such as rheumatoid arthritis". - GTCB Gtc Biotherapeutics Inc
2010-03-01 Landmark Arthritis Health Report Has Consumers Seeking FlexoplexA new study published in Arthritis and Rheumatism suggests that signs of rheumatoid arthritis may present in the blood years before symptoms arise. Inflammatory proteins called cytokines, which are known to be present in synovial tissue after rheumatoid arthritis develops, appear to reach elevated levels in the tissue years before the condition manifests. In a late January article that was published on the popular health website, , the article revealed a landmark arthritis study that could enable people to be able to test for RA (rheumatoid arthritis) using a blood test early onlong before the disease sets inso they could better prepare for it, or even stave it off by taking early preventative measures and incorporating the proper lifestyle changes. PR: A recent health report has shown that there may be a blood test in the works that can diagnose RA (rheumatoid arthritis) and other forms of the disease early onpromoting consumer awareness for effective preventative and all-natural treatment supplements for arthritis, like Flexoplex. Manalapa - PRESS RELEASE
2010-02-27 Alan Lee Casey, 56: Photographer, painter despite rheumatoid arthritisYears of medication to treat the rheumatoid arthritis took a toll on the bankers vital organs. Tuesday, Alan Lee Casey died from complications of chronic diseases at Tranquility House in Marietta. He was 56. The funeral will be held at 11 a. m. Friday at West Ridge Church in Dallas. West Cobb Funeral Home is in charge of arrangements. Signs of rheumatoid arthritis appeared when Alan Casey was in his early 20s. The disease gradually worsened, but he fulfilled his artistic pursuits despite the affliction. Signs of rheumatoid arthritis appeared when Alan Casey was in his early 20s. The disease gradually worsened, but he fulfilled his artistic pursuits despite the affliction. - Alan Lee Casey 56 Photographer painter rheumatoid arthritis News AJC Obituaries
2010-02-26 Prozac, Celexa show promise for rheumatoid arthritis treatment - Oneindia NewsFor the current study, researchers used a CIA mouse model due to the similarities to human RA, including synovitis, bone erosion and pannus formation. At the onset of arthritis, mice were treated daily for 7 days with a dose of 10 or 25 mg/kg of fluoxetine and 25 mg/kg of citalopram. At the lower dose of fluoxetine the mice showed a small reduction in the clinical score (a combined measure of redness, swelling and joint mobility/deformity) and a slower increase in paw swelling. At a dose of 25 mg/kg, fluoxetine halted disease progression and no further elevation was noted in the clinical score or paw swelling. Washington (ANI): A new British study has found that fluoxetine and citalopram exhibit anti-inflammatory effects. - Prozac Celexa show promise for rheumatoid arthritis treatment
|
|
||||||||||||||||||
|
||||||||||||||||||||
